Search results for " cannabis"
showing 10 items of 37 documents
Disabilità e dolore: il caso della cannabis terapeutica. Fisionomia e limiti del diritto alla cura nel decreto del Ministero della Salute 9 novembre …
2022
Il contributo illustra l’originale struttura del mercato della cannabis terapeutica, ricostruendo la legislazione italiana in materia, di cui si mette in luce la dubbia compatibilità con i principi di libera circolazione e di concorrenza. La specialità del settore è comunemente giustificata alla luce delle esigenze di salute pubblica, dell’ordine pubblico e della pubblica sicurezza la cui tutela è sottesa anche ai più recenti interventi normativi: specialità che non consente tuttavia di giudicare la regolazione della cannabis terapeutica conforme all’interpretazione consolidata degli articoli 49, 52, 56, 106 T.f.Ue e alla altrettanto stabile giurisprudenza della Corte costituzionale italia…
Estudio del consumo de alcohol y otras drogas en alumnos/as de los cursos de monitores/as de ocio y tiempo libre
2009
Partimos de la idea de que las drogas alteran nuestras emociones, nuestras capacidades y actitudes y nos preguntamos si los/as alumnos/as que realizan los cursos de monitores/ as de ocio y tiempo libre consumen drogas y cómo es dicho consumo, ya que después, van a trabajar con menores y jóvenes, Para averiguarlo, utilizamos el Test de Identifi cación de los Trastornos Debidos al Consumo de Alcohol (AUDIT), para identifi car a las personas con un patrón de consumo perjudicial o de riesgo de alcohol. Y para conocer el resto de sustancias consumidas utilizaremos La Historia Toxicológica, mencionando para cada sustancia; inicio, frecuencia y tiempo de consumo. Como resultados destacamos que un …
Durata di psicosi non trattata e consumo di cannabis in un campione di pazienti al primo episodio psicotico
2011
Introduzione: la durata di psicosi non trattata (DUP) nei pazienti affetti da psicosi all’esordio rappresenta un fattore predittivo dell’outcome e del decorso del disturbo (Perkins, 2005). La relazione tra consumo di cannabis e DUP è ancora controversa. In questo lavoro viene analizzato il rapporto tra DUP ed età di esordio, consumo di cannabis, funzionamento cognitivo, livello di istruzione e stato di occupazione in un gruppo di pazienti affetti da psicosi all’esordio reclutati nell’ambito dello studio SGAP (Sicilian Genetic and Psychosis) svolto in collaborazione con l’Institute of Psychiatry, King's College of London. Metodologia: sono stati reclutati 74 pazienti di età compresa tra 18 e…
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
2019
Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder. Methods: We included patients aged 18–64 years who presented to psychiatric services in 11 sites across Europe and Brazil with first-episode psychosis and recruited controls representative of the local populations. We applied adjusted logistic regression models to the data to estimate which patterns of canna…
Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice
2017
Chronic cannabinoid consumption is an increasingly common behavior among teenagers and has been shown to cause long-lasting neurobehavioral alterations. Besides, it has been demonstrated that cocaine addiction in adulthood is highly correlated with cannabis abuse during adolescence. Cocaine consumption and subsequent abstinence from it can cause psychiatric symptoms, such as psychosis, cognitive impairment, anxiety, and depression. The aim of the present research was to study the consequences of adolescent exposure to cannabis on the psychiatric-like effects promoted by cocaine withdrawal in adult mice. We pre-treated juvenile mice with the cannabinoid CB1 receptor agonist WIN 55212-2 (WIN)…
Effects of a Brief Web-Based "Social Norms"-Intervention on Alcohol, Tobacco and Cannabis Use Among German University Students: Results of a Cluster-…
2021
Background and Aim: “Social norms” (SN)-interventions are aimed at changing existing misperceptions regarding peer substance use by providing feedback on actual norms, thereby affecting personal substance use. It is unknown whether SN-intervention effects previously demonstrated in US students can be replicated in German students. The aim of the INSIST-study was to examine the effects of a web-based SN-intervention on substance use.Design: Cluster-controlled trial.Setting: Eight Universities in Germany.Participants and Measurements: Students were recruited at four intervention vs. four delayed intervention control Universities. 4,463 students completed baseline, 1,255 students (59% female) …
Adverse effects of heavy cannabis use: even plants can harm the brain.
2020
The spread of laws legalising cannabis for medicinal or recreational use has been accompanied by more relaxed attitudes towards cannabis. Data from the United States show that in states that have legalised cannabis, prevalence of daily, weekly, and monthly cannabis use was 11.3%, 18.3%, and 25.0% respectively, whereas in countries where it is still illegal, it was lower (7.4%, 11.6%, and 16.8% respectively). Evidence indicates a trend of increase among adolescents, a particular vulnerable category for the initiation of substance use. In parallel, we have seen the concentration of THC (D-9-tetrahydrocannabinol) in the cannabis sold both in the United States and in Europe rising and those typ…
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study
2021
The work was supported by: Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust to DQ; DFG Heisenberg professorship (no. 389624707) to UR. National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by t…
FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CA…
2018
Background: Robust evidence has demonstrated that cannabis use increases the risk to develop psychotic disorders. However, a limited number of studies have investigated if and how cannabis use influences psychopathology profiles at first episode psychosis (FEP). Based on the evidence that dopamine dysfunction contributes to explain positive symptoms in psychosis, and that the main cannabis’ psychoactive component, Δ9-Tetrahydrocannabinol (THC), modulates the dopamine system, we hypothesise that: 1) positive symptoms at FEP are more common among psychotic patients who used cannabis compared with never users; 2) this association is a dose-response relationship. Methods: We analyzed a sample o…